Shares of MyoKardia are soaring about 60% in Monday’s pre-market trading after the biopharma company agreed to be acquired by Bristol Myers Squibb …
Bluebird Bio (BLUE) priced an offering of 9.09 million shares of its common stock at $55 each, the company said late on Monday.
Clovis Oncology Inc (NASDAQ:CLVS) and Bristol-Myers Squibb Co (NYSE:BMY) announced the companies have entered into a clinical collaboration agreement to evaluate the combination of …
Bristol-Myers Squibb Co (NYSE:BMY) announced the U.S.
There was more terrible economic news today as core durable goods orders fell for the 21st straight month which is the longest decline …
Bristol-Myers Squibb Co (NYSE:BMY) announced that the U.S.
Bristol-Myers Squibb Co (NYSE:BMY) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended the approval …
In a research report released yesterday, Leerink Swann analyst Seamus Fernandez reiterated an Outperform rating on shares of Bristol-Myers Squibb Co (NYSE:BMY), after the …
Bristol-Myers Squibb Co (NYSE:BMY) announced new data across eight tumor types evaluating Opdivo (nivolumab) and Yervoy (ipilimumab), as monotherapy or in combination, as well …
Bristol-Myers Squibb Co (NYSE:BMY) and Nektar Therapeutics (NASDAQ:NKTR) announced a new clinical collaboration to evaluate Bristol-Myers Squibb’s Opdivo (nivolumab) with Nektar’s investigational medicine, NKTR-214, …
